EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Viela Bio's enterprise value is $2,545.22 Mil.
Viela Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $11.65 Mil. Therefore, Viela Bio's EV-to-Revenue for today is 218.44.
The historical rank and industry rank for Viela Bio's EV-to-Revenue or its related term are showing as below:
VIE'
s EV-to-Revenue Range Over the Past 10 Years
Min: 19.73 Med: 45.2 Max: 218.97
Current: 218.44
During the past 3 years, the highest EV-to-Revenue of Viela Bio was 218.97. The lowest was 19.73. And the median was 45.20.
VIE's EV-to-Revenue is not ranked
in the Biotechnology industry.
Industry Median: 7.63
vs VIE: 218.44
As of today (2024-04-25), Viela Bio's stock price is $53.01.
Viela Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.21. Therefore, Viela Bio's PS Ratio for today is 250.05.
Viela Bio EV-to-Revenue Historical Data
The historical data trend for Viela Bio's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Viela Bio's EV-to-Revenue
For the Biotechnology subindustry, Viela Bio's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viela Bio's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Viela Bio's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Viela Bio's EV-to-Revenue falls into.
Viela Bio's current Enterprise Value is $2,545.22 Mil.
Viela Bio's Revenue for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $11.65 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viela Bio's share price for today is $53.01.
Viela Bio's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.21.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viela Bio EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Viela Bio's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Viela Bio Inc is a clinical-stage biotechnology company engaged in developing and commercializing transformative treatments for severe inflammation and autoimmune diseases. Its product inebilizumab, is a humanized monoclonal antibody, designed to target CD19, a molecule expressed on the surface of a broad range of immune system B cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VIE has been successfully added to your 